Sukhani told CNBC-TV18, "You buy at new highs because topping out process takes a lot of time. That hasn't even begun. I don't think Bata India is going to top out in a hurry. At some point it will. So the three days sideways movement in Bata India is a substitute for a correction and the chances are that it's going to see much better levels probably maybe even today if the markets remain choppy and that's the time when we want to buy what is now a small dip."
He further added, "Mcleod Russel has come in my buy lists earlier also, after being fairly bearish on that this stock has turned around. From Rs 170 it has moved to Rs 270. Yesterday it showed signs that the highs that it is making are likely to be crossed. It closed cheerful and it's on the verge of a resistance breakout. So it's not exactly Bata but in its small way it's doing the right things, rallying, moving towards new highs for this uptrend. It's a buying opportunity. The chances are that this rally will continue."
Subscribe to:
Post Comments (Atom)
-
Lupin’s Q2FY17 revenues were in-line with our estimates. Revenues grew by 32% YoY to INR 42.1 bn (as compared to our estimate of INR 41.9 b...
-
Volume grew by 4.2% QoQ, best in last 12 quarters. The company expects strong volume momentum to continue despite the mixed view on clie...
-
Sukhani told CNBC-TV18, “I would still buy Ranbaxy Labs. It was in my buy list in the morning and this tells viewers that we go wrong all th...
No comments:
Post a Comment